THOMPSON KIMBERLY KRAIG (CEO, CFO) sold 0.0% of their position (65K shares) of KRAIG BIOCRAFT LABORATORIES, INC. on the open market
Insider sale on the open market — a minor trim. Check remaining position size for full context.
S · 3 sales
Filed: 5/27/2022ACC: 0001493152-22-015366
DirectorOfficer10% Owner· CEO, CFO
Since Dec 2020
-65K
Net shares
Net seller
$0.00
Total acquired
3
Open market trades
0B · 3S
3
Total transactions
65K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−30K
Price / share
—
Trade value
—
% of position
0.0%
5/24/2022
202.82M→202.79M
Common Stock
Direct
Shares
−25K
Price / share
—
Trade value
—
% of position
0.0%
5/25/2022
202.79M→202.77M
Common Stock
Direct
Shares
−10K
Price / share
—
Trade value
—
% of position
0.0%
5/26/2022
202.77M→202.76M
Total
Net shares
−65K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/24/2022 | S · Sale | −30K | — | — | 0.0% | 202.82M | 202.79M |
| Common Stock Direct | 5/25/2022 | S · Sale | −25K | — | — | 0.0% | 202.79M | 202.77M |
| Common Stock Direct | 5/26/2022 | S · Sale | −10K | — | — | 0.0% | 202.77M | 202.76M |
| Total | −65K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported